GLYCOBIOLOGY

Glycobiology, published monthly by Oxford University Press in the United Kingdom (ISSN 0959-6658), is a distinguished international journal dedicated to advancing the field of glycobiology and its interdisciplinary connections. The journal publishes high-quality original research and reviews covering a broad spectrum of topics, including the structure, function, and biosynthesis of glycoproteins and glycolipids, glycosylation modifications, glycogenetics, and the critical roles of glycans in cellular signaling, development, and disease mechanisms. As an SCI-indexed publication, Glycobiology maintains a strong reputation within the scientific community, with an impact factor that has consistently ranged between 3.5 and 4.5 in recent years, and it is typically classified in the second or third quartile of the Biochemistry and Molecular Biology category by the Chinese Academy of Sciences. While the journal operates on a hybrid model offering partial open access options, it is known for its rigorous peer-review process and high submission standards, resulting in a competitive acceptance rate that favors innovative and methodologically sound studies. This selective approach ensures that the content remains at the forefront of the discipline, appealing to a specialized audience of researchers, clinicians, and academics interested in the fundamental and translational aspects of carbohydrate biology, although the journal’s specialized focus and hybrid access model may limit its broader dissemination compared to fully open-access platforms.